Owner-operators of independent retail pharmacies (nearly 19,000 locations, $103B market) are fighting a survival crisis driven by PBM reimbursement that routinely falls below drug acquisition cost. They need tools, software, and consulting to protect margins, diversify into clinical services, and survive aggressive PBM audits before their doors close for good.
Independent pharmacies are closing at roughly one per day nationwide, and over 600 closed in the first nine months of 2025 alone — every closure is a pharmacist-owner desperately searching for a survival solution before they become the next statistic, driving urgent demand for any tool that protects revenue.
The CAA 2026 law now mandates semiannual PBM transparency reports and bans rebate-driven compensation starting in 2028 — a hard regulatory deadline is forcing every independent owner to renegotiate contracts and overhaul operations right now, creating a consulting and software buying cycle.
CMS rule changes are projected to expand MTM billing opportunities fourfold by 2027 — owners who set up the right clinical workflow and documentation software today will capture a PBM-proof revenue stream, making clinical infrastructure products a hot buy across all 18,960 locations.
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.